Armstrong, A. J., Mottet, N., Iguchi, T., Szmulewitz, R. Z., Holzbeierlein, J., Villers, A., … Azad, A. (2022). Radiographic progression in the absence of prostate-specific antigen (PSA) progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analysis of ARCHES. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).

Armstrong, Andrew J., Nicolas Mottet, Taro Iguchi, Russell Zelig Szmulewitz, Jeffrey Holzbeierlein, Arnauld Villers, Antonio Alcaraz, et al. “Radiographic progression in the absence of prostate-specific antigen (PSA) progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analysis of ARCHES.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.

Armstrong AJ, Mottet N, Iguchi T, Szmulewitz RZ, Holzbeierlein J, Villers A, et al. Radiographic progression in the absence of prostate-specific antigen (PSA) progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analysis of ARCHES. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.

Armstrong, Andrew J., et al. “Radiographic progression in the absence of prostate-specific antigen (PSA) progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analysis of ARCHES.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.

Armstrong AJ, Mottet N, Iguchi T, Szmulewitz RZ, Holzbeierlein J, Villers A, Alcaraz A, Alekseev B, Shore ND, Gomez-Veiga F, Rosbrook B, Zohren F, Lee H-J, Haas GP, Stenzl A, Azad A. Radiographic progression in the absence of prostate-specific antigen (PSA) progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analysis of ARCHES. JOURNAL OF CLINICAL ONCOLOGY. 2022.